In this article, we will look at the 13 Most Undervalued Long-Term Stocks to Buy According to Analysts.
On March 4, Tom Lee from Fundstrat appeared on a CNBC television interview to discuss market conditions amid geopolitical tensions. Lee noted that there is no doubt that there have been scary headlines all around, as no one wants to see the US in a conflict. However, the markets have been much more resilient than expected, considering the headlines. Lee highlighted that the markets are bottoming, but more importantly, this has provided a reset, suggesting that there will be numerous opportunities once we move past this phase.
He highlighted that some of the signs of the market reaching a bottom include VIX making a spike over 40, continued gold sell-off, and the market turning green. Lee believes that it seems we are close to a rebound. He pointed out that the Mag Seven and software have been through most of their declines and are expected to outperform, mainly because they are considered safe havens amid tensions, and secondly, because of AI.
With that, let’s take a look at the 13 Most Undervalued Long-Term Stocks to Buy According to Analysts.
Our Methodology
We sifted through reputable financial media to identify stocks that are trading below a forward P/E of 15, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
13 Most Undervalued Long-Term Stocks to Buy According to Analysts
13. JPMorgan Chase & Co. (NYSE:JPM)
JPMorgan Chase & Co. (NYSE:JPM) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Financial Times reported that JPMorgan Chase & Co. is tightening lending to private credit funds by marking down the value of certain loans used as collateral.
The tightening is mainly for software companies vulnerable to AI disruption. This precautionary move limits borrowing capacity without triggering margin calls and reflects broader caution amid private credit market volatility.
According to the report, JPMorgan views software firms as high-risk due to the onset of AI.
Jamie Dimon, JPMorgan’s chief executive, noted being more prudent with such assets. Moreover, Executive Troy Rohrbaugh noted that the bank is being more conservative compared to its peers as it uses individual analysis, macro factors, and public proxies for valuations, revaluing proactively rather than waiting for crises. Following the release, Private credit stocks fell sharply as Ares declined 5.2%, KKR -2.7%, Blackstone -2.1%, and Apollo -2%.
JPMorgan Chase & Co. is a New York-based financial services company operating through three segments: Consumer & Community Banking, Commercial & Investment Banking, and Asset & Wealth Management.
12. Bank of America Corporation (NYSE:BAC)
Bank of America Corporation (NYSE:BAC) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 10, Bank of America Corporation (NYSE:BAC) presented at the RBC Capital Markets Global Financial Institutions Conference. At the conference, Co-President Dean Athanasia noted the bank’s strategic priorities, robust financial performance, and optimistic outlook amid market volatility.
Management highlighted that consumer spending remains strong at 5% to 6% year-over-year growth, especially in entertainment and travel, supporting a K-shaped economy where higher-income groups show faster wage and spending gains. Bank of America Corporation noted that its wealth management oversees $5.5 trillion in assets under management, and the bank targets 4% to 5% medium-term net new asset growth. This is complemented by $600 billion in workplace benefits for 24,000 corporate clients.
Notably, the bank spends $13 billion on technology annually, including $4 billion for new initiatives. These new initiatives include AI tools like the Erica assistant, handling over 3 billion transactions. Looking ahead, management expects Basel III Endgame proposals soon, which are expected to potentially ease capital requirements. Lastly, the bank is focused on maintaining a CET1 ratio of 11.4%.
Bank of America Corporation delivers financial solutions to individuals, small and mid-sized enterprises, large institutions, and governments. It has a global presence with expertise in consumer banking, wealth & investment management, and capital markets. The company offers a range of financial products & services across its four broad segments.
11. Toyota Motor Corporation (NYSE:TM)
Toyota Motor Corporation (NYSE:TM) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Reuters reported that Toyota Motor Corporation (NYSE:TM) is recalling 550,007 vehicles in the United States over faulty seat-back issues, which may cause the seat lock failure.
The National Highway Traffic Safety Administration (NHTSA) noted that this issue increases the risk of injury. According to the report, the recalled vehicles include 2021 to 2024 Highlander and Highlander Hybrid vehicles. These models are facing issues where the second‑row seat backs may not lock into place during adjustment.
The share price of Toyota Motor Corporation has slipped more than 4% following the release (as of 13 Mar, 4:07 pm GMT-4).
Toyota Motor Corporation is a leading Japanese automaker that primarily designs, manufactures, and sells a wide range of vehicles, including sedans, SUVs, trucks, and minivans, along with parts and accessories.
10. Wells Fargo & Company (NYSE:WFC)
Wells Fargo & Company (NYSE:WFC) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 6, Evercore ISI reiterated a Buy rating on Wells Fargo & Company but lowered the price target from $105 to $98.
The rating is based on the firm’s meeting with the management in San Francisco. Evercore noted that it came back confident regarding general fundamental trends, with the exception of some headwinds and an increasingly uneasy landscape.
The firm noted that Wells Fargo reaffirmed its core financial outlook amid macroeconomic headwinds, including the Iran conflict, AI uncertainties, and broader economic volatility. Management highlighted no material shifts in net interest income, loan/deposit growth, or expenses.
Moreover, the company described AI as a fast-evolving factor sparking investor concerns but not yet posing significant risks to deposits, wealth management, or fee income streams. Wells Fargo noted that consumer resilience remains steady in card and auto lending, although the bank is watching for delayed AI effects on US unemployment.
Wells Fargo & Company is engaged in a diverse array of financial services such as banking, mortgages, investments, and commercial finance solutions. It serves consumers, small businesses, and large institutions, offering unique products and services tailored to specific requirements.
9. Novo Nordisk A/S (NYSE:NVO)
Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 9, Novo Nordisk A/S (NYSE:NVO) announced its partnership with Hims & Hers. The deal entails access to Novo’s GLP-1 drugs, Ozempic and Wegovy, at Hims & Hers’ platform.
Management noted that as part of this deal, Hims & Hers will sell FDA-approved Ozempic injections and Wegovy in tablet form and injections at “affordable self-pay prices” matching other telehealth sites. Moreover, Hims and Hers will also stop selling and advertising compounded GLP-1s; as a result, existing patients will have the opportunity to use FDA-approved treatments.
In addition, Novo Nordisk is also dropping its patent lawsuit against Hims & Hers, but can refile later. NVO’s CEO Mike Doustdar noted this as a “win for patients” by prioritizing safe, proven FDA-approved meds over riskier compounds. It counters competition from telehealth firms undercutting prices with unapproved knockoffs, which have surged amid GLP-1 demand.
Novo Nordisk A/S is a global healthcare company that develops, manufactures, and markets medicines for serious chronic diseases. It is a leader in diabetes care (including insulin and Ozempic), obesity management (Wegovy), haemophilia care, and rare endocrine disorders.
8. U.S. Bancorp (NYSE:USB)
U.S. Bancorp (NYSE:USB) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, U.S. Bancorp (NYSE:USB) presented at the RBC Capital Markets Global Financial Institutions Conference. The bank highlighted positive updates regarding strong performance and future prospects.
Management noted exceeding Q1 guidance for net interest and fee income, driven by strong loan growth and capital market activity. The bank also highlighted that the BTIG acquisition is projected to boost annual revenue by $175 million to $200 million, thereby strengthening capital markets while maintaining a negligible 2026 EPS impact.
Financially, U.S. Bancorp noted that it remains on track to reach the high end of its 3% to 4% year-over-year growth. Moreover, the fee income is also expected in the higher end of the 5% to 6% growth range. The performance is driven by growth in payments and capital markets. Looking ahead, the company is targeting 4% to 6% net revenue growth in 2026 with more than 200 bps positive operating leverage, focusing on consumer deposits and fee expansion.
U.S. Bancorp operates as a financial services holding company. Its businesses include Wealth, Corporate, Commercial, and Institutional Banking, Consumer and Business Banking, Payment Services, and Treasury and Corporate Support.
7. Barclays PLC (NYSE:BCS)
Barclays PLC (NYSE:BCS) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, analyst Chris Hallam of Goldman Sachs maintained a Buy rating on Barclays PLC (NYSE:BCS) and raised the price target from p550 to p590.
The analyst said in a research note that he sees Barclays and other European banks as attractive in terms of valuations relative to the risks. He noted that the recent declines in the sector due to fears of AI disruptions, private credit risks, and Middle East tensions are overblown compared to the limited impact on earnings.
He highlighted that geopolitically driven credit losses are expected to be offset by higher net interest income from elevated rates. Moreover, Hallam noted that Barclays and its peers trade at a discount to US banks and offer double-digit earnings growth potential despite risks. He highlighted that the bank now relies less on traditional lending, with diversified revenue streams and robust capital buffers.
Headquartered in London, Barclays PLC is a bank holding company that provides credit cards, retail banking, wealth management, and corporate and investment banking services.
6. Elevance Health, Inc. (NYSE:ELV)
Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Mizuho analyst Ann Hynes lowered the firm’s price target on Elevance Health, Inc. (NYSE:ELV) from $413 to $350 and maintained a Buy rating on the stock.
The analyst noted that the reduced price target reflects the company’s reaffirmed guidance amid the ongoing Centers for Medicare and Medicaid Services scrutiny. Hynes said in a research note that the company disclosed that the Centers for Medicare and Medicaid Services (CMS) sanctions target historical data submission issues. These involve noncompliance in reporting diagnosis codes through improper methods, potentially leading to enrollment suspensions.
Despite the challenges, the company reiterated its 2026 outlook at a competitor event, stating the sanctions relate only to past processes and do not affect current risk-adjustment operations. Hynes noted that the current 2026 estimates already factor in any financial impacts, hence she reiterated a Buy rating on the stock.
Elevance Health, Inc. is a health company that operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a range of health plans and services, while the CarelonRx segment manages pharmacy services. The Carelon Services segment offers various healthcare-related services by integrating behavioral, physical, pharmacy, and social services.
5. Truist Financial Corporation (NYSE:TFC)
Truist Financial Corporation (NYSE:TFC) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 10, Truist Financial Corporation (NYSE:TFC) reported leadership appointments in the company’s Enterprise Payments business to capitalize on the strong growth in 2025.
The company highlighted 13% treasury management fees from new clients and deeper relationships in 2025. Management also noted that the growth in fees stemmed from commercial and middle-market clients consolidating payment and cash-management activities with Truist.
To capitalize on this growth, the company announced the appointment of Geoff Gursel as Head of Middle Market Payments Sales and Steven Shipp as Head of Small Business Payments Sales. Management noted that Geoff Gursel comes from Citi with more than 20 years of experience in treasury and payments. Moreover, Steven Shipp has more than 25 years of experience at Truist Financial Corporation.
Truist Financial Corporation operates as a U.S. financial holding company. It focuses on providing banking services using its corporate and commercial banking, wealth management, and consumer banking companies. Its headquarters are located in Charlotte, North Carolina.
4. MetLife, Inc. (NYSE:MET)
MetLife, Inc. (NYSE:MET) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, TD Cowen lowered the firm’s price target on MetLife, Inc. (NYSE:MET) from $91 to $88, while maintaining a Buy rating on the stock.
The firm noted updating its financial model after the company’s Q4 2025 earnings were reported on February 4. During the quarter, the company grew its revenue by 22.56% year-over-year to $24.19 billion, but missed estimates by $7.44 billion. The EPS of $2.49 topped consensus by $0.15.
Management noted that the quarterly performance was driven by a 12% year-over-year increase in Group Benefits adjusted earnings, which reached $465 million in Q4. Moreover, the Retirement and Income Solutions earnings also improved 18% year-over-year to $454 million.
Notably, the MetLife Investment Management, which is the newly formed business segment, delivered $60 million in adjusted earnings for 2025. The segment’s assets under management reached $742 billion, up from about $600 billion a year earlier following the PineBridge acquisition.
Looking ahead, the company expects fiscal 2026 to see double-digit adjusted EPS growth, along with adjusted ROE of 15% to 17%.
MetLife, Inc. provides insurance, annuities, employee benefits, and asset management services across the United States and international markets. Its operations include life, dental, disability, property, and casualty insurance, as well as retirement and savings products offered to individuals and institutions.
3. Carnival Corporation & plc (NYSE:CCL)
Carnival Corporation & plc (NYSE:CCL) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Stifel analyst Steven Wieczynski lowered the firm’s price target on Carnival Corporation & plc (NYSE:CCL) from $40 to $35, while maintaining a Buy rating on the shares.
The analyst noted that the reduced price target reflects the ongoing geopolitical tensions. He said in a research note that investor sentiment regarding the cruise industry has gone from solid to unstable in the blink of an eye. He added that the expectations for the company’s upcoming earnings and guidance have been lowered significantly.
Steven Wieczynski highlighted that while the fundamentals of the industry remain strong, investors won’t care about it until the geopolitical backdrop cools down. He noted the increased fuel prices due to the conflicts as one of the key reasons behind the lowered price target.
Carnival Corporation & plc (NYSE:CCL) is a global operator of cruise and leisure services in the travel sector, offering cruise experiences, onboard amenities, and passenger experiences under several brands across multiple regions.
2. Trip.com Group Limited (NASDAQ:TCOM)
Trip.com Group Limited (NASDAQ:TCOM) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 9, CITIC Securities maintained a Buy rating on the stock with a price target of HK$466.
The rating follows the company’s Q4 2025 earnings released on February 26. The company grew its quarterly revenue by 27.47% year-over-year to $2.24 billion and topped expectations by $90.28 million. The EPS of $0.72 also topped the consensus by $0.05. Management noted growth to be driven by resilient travel demand. Notably, the accommodation reservation revenue for the quarter grew 21% year-over-year to $899 million, while the transportation ticketing revenue was up 12% during the same time.
Moreover, net income for the quarter also grew to RMB4.3 billion, up from RMB2.2 billion in Q4 2024. CEO Jane Sun noted that inbound travel was one of the key factors contributing to growth in 2025. Management highlighted that for the full-year the company served more than 20 million inbound travelers and witnessed a 60% increase in overall bookings at the company’s OTA platform.
Trip.com Group Limited, through its subsidiaries, operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours, in-destination, corporate travel management, and other travel-related services in China and internationally.
1. Charter Communications, Inc. (NASDAQ:CHTR)
Charter Communications, Inc. (NASDAQ:CHTR) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts. On March 11, Charter Communications, Inc. (NASDAQ:CHTR) announced expanding its partnership with RingCentral to offer Spectrum Business customers UCX, a unified platform.
UCX brings together RingCentral’s AI-powered tools for communications, contact centers, and analytics to the Charter Communications’ network. The partnership brings RingCX, which is an AI-driven contact center that can handle voice, video, SMS, web chat, social media, and more. Moreover, an AI Conversation Expert will also be added for Spectrum Business customers, which provides various services, including call transcriptions, spotting sales risks, and synchronizing insights to CRMs automatically.
Management noted that the combination brings end-to-end visibility from customer contact to sales. It enables faster resolutions, better decisions, and growth. Moreover, the solution is tailored for regulated sectors including healthcare, education, government, and financial services.
Both companies are set to showcase UCX with RingCentral at HIMSS 2026 and Enterprise Connect in Las Vegas.
Charter Communications, Inc. is an American broadband connectivity company and cable operator that provides internet, video, mobile, and voice services.
